✦ LIBER ✦

A366 Relevance of Conventional Prognostic Factors in Multiple Myeloma (MM) in the Era of Novel Therapies

✍ Scribed by Kapoor, P; Kyle, RA; Kumar, SK; Rajkumar, SV; Greipp, PR; Witzig, TE; Dispenzieri, A; Lacy, MQ; Lust, JA; Hayman, SR; Buadi, FK; Zeldenrust, SR; Dingli, D; Russell, SJ; Gertz, MA

Book ID: 118629333
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 84 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70560-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic Transplantation in Multiple M

Allogeneic Transplantation in Multiple Myeloma: A Potential Renaissance in the Era of Novel Therapies?

✍ Richardson, Paul 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Multiple Myeloma in the Era of Novel Age

Multiple Myeloma in the Era of Novel Agents

✍ Meletios A. Dimopoulos; Michel Attal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Prognostic significance of apoptotic ind

Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib

✍ Jiri Minarik; Vlastimil Scudla; Marta Ordeltova; Jaroslav Bacovsky; Tomas Pika; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Proliferative activity of plasma cells i

Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients

✍ R. García-Sanz; M.I. González-Fraile; G. Mateo; J.M. Hernández; M.C. López-Berge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 158 KB

## Abstract Although multiple myeloma (MM) is predominantly a disease of the elderly, few studies have focused on the identification of prognostic factors in this group of patients. Four hundred twenty five MM patients >65 years were uniformly treated with chemotherapy (MP or VCMP/VBAD). Multivaria

The Albumin and Monoclonal Protein Ratio

The Albumin and Monoclonal Protein Ratio as Prognostic Marker for Multiple Myeloma in the Era of Novel Agents

✍ Katalin Kádár, Krisztina Wolf, Judit Tábori, István Karádi, Judit Várkonyi 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 369 KB

Incidence of extramedullary disease in p

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

✍ Short, K Detweiler; Rajkumar, S V; Larson, D; Buadi, F; Hayman, S; Dispenzieri, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB